Compared to the previous survival rates of 9 and 12 %, BOOMER
And this was just the prelude to the trial proper
Ann: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L, page-10
-
- There are more pages in this discussion • 838 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
0.005(0.43%) |
Mkt cap ! $1.295B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.16 | $1.11 | $4.682M | 4.125M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 24 | 29562 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 59054 | 13 |
View Market Depth
| Last trade - 12.31pm 26/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |